statistiche ricercatore

Continente	#
NA - Nord America	1.772
EU - Europa	654
AS - Asia	560
SA - Sud America	84
Continente sconosciuto - Info sul continente non disponibili	23
AF - Africa	19
OC - Oceania	1
Totale	3.113

Nazione	#
US - Stati Uniti d'America	1.740
IT - Italia	220
SG - Singapore	189
GB - Regno Unito	147
CN - Cina	105
VN - Vietnam	72
HK - Hong Kong	68
SE - Svezia	68
BR - Brasile	63
DE - Germania	46
FR - Francia	37
BD - Bangladesh	29
RU - Federazione Russa	29
FI - Finlandia	26
TR - Turchia	25
UA - Ucraina	17
ID - Indonesia	14
IN - India	13
CA - Canada	12
BG - Bulgaria	10
ES - Italia	9
KR - Corea	9
AR - Argentina	8
CZ - Repubblica Ceca	8
NL - Olanda	7
ZA - Sudafrica	7
BE - Belgio	6
IQ - Iraq	6
JP - Giappone	6
MX - Messico	6
JM - Giamaica	5
LT - Lituania	5
MY - Malesia	5
MA - Marocco	4
PL - Polonia	4
AE - Emirati Arabi Uniti	3
AT - Austria	3
CO - Colombia	3
IR - Iran	3
VE - Venezuela	3
AZ - Azerbaigian	2
BA - Bosnia-Erzegovina	2
CR - Costa Rica	2
DZ - Algeria	2
EC - Ecuador	2
IE - Irlanda	2
KE - Kenya	2
KG - Kirghizistan	2
PE - Perù	2
PH - Filippine	2
RS - Serbia	2
SA - Arabia Saudita	2
SK - Slovacchia (Repubblica Slovacca)	2
TN - Tunisia	2
UY - Uruguay	2
AU - Australia	1
BB - Barbados	1
BH - Bahrain	1
BZ - Belize	1
CH - Svizzera	1
CL - Cile	1
EG - Egitto	1
EU - Europa	1
GD - Grenada	1
HN - Honduras	1
IL - Israele	1
JO - Giordania	1
LA - Repubblica Popolare Democratica del Laos	1
MD - Moldavia	1
NI - Nicaragua	1
NO - Norvegia	1
PA - Panama	1
PK - Pakistan	1
SD - Sudan	1
SI - Slovenia	1
SV - El Salvador	1
Totale	3.091

Nome	#
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes	489
A 5-year clinical follow-up study from the Italian National Registry for FSHD	411
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry	389
Large scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy (FSHD)	355
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy.	341
The Italian FSHD registry: An enhanced data integration and analytics framework for smart health care	310
Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis	295
D4Z4 reduced allele in myopathic subjects with no FSHD phenotype: why inconsistency between molecular and clinical data should prompt us to further investigations.	284
Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy	239
Totale	3.113

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	194	0	0	0	10	12	13	17	23	30	15	53	21
2022/2023	276	28	33	25	18	49	24	6	26	28	1	20	18
2023/2024	182	2	11	11	16	22	11	11	22	8	13	9	46
2024/2025	441	18	17	7	32	78	67	27	51	54	16	29	45
2025/2026	813	48	19	45	91	145	66	120	29	73	73	64	40
2026/2027	137	23	39	33	42	0	0	0	0	0	0	0	0
Totale													3.113